Corrine Corrina R Hartford, Roshan L Shrestha, Lorinc Pongor, Yongmei Zhao, Xiongfong Chen, Caroline Fromont, Ritu Chaudhary, Xiao Ling Li, Katherine R Pasterczyk, Ravi Kumar, Bruna R Muys, Dimitrios Tsitsipatis, Raj Chari, Myriam Gorospe, Mirit I Aladjem, Javed Khan, Munira A Basrai, Ioannis Grammatikakis, Ashish Lal
{"title":"Context-Dependent Function of Long Noncoding RNA <i>PURPL</i> in Transcriptome Regulation during p53 Activation.","authors":"Corrine Corrina R Hartford, Roshan L Shrestha, Lorinc Pongor, Yongmei Zhao, Xiongfong Chen, Caroline Fromont, Ritu Chaudhary, Xiao Ling Li, Katherine R Pasterczyk, Ravi Kumar, Bruna R Muys, Dimitrios Tsitsipatis, Raj Chari, Myriam Gorospe, Mirit I Aladjem, Javed Khan, Munira A Basrai, Ioannis Grammatikakis, Ashish Lal","doi":"10.1128/mcb.00289-22","DOIUrl":null,"url":null,"abstract":"<p><p><i>PURPL</i> is a p53-induced lncRNA that suppresses basal p53 levels. Here, we investigated <i>PURPL</i> upon p53 activation in liver cancer cells, where it is expressed at significantly higher levels than other cell types. Using isoform sequencing, we discovered novel <i>PURPL</i> transcripts that have a retained intron and/or previously unannotated exons. To determine <i>PURPL</i> function upon p53 activation, we performed transcriptome sequencing (RNA-Seq) after depleting <i>PURPL</i> using CRISPR interference (CRISPRi), followed by Nutlin treatment to induce p53. Strikingly, although loss of <i>PURPL</i> in untreated cells altered the expression of only 7 genes, loss of <i>PURPL</i> resulted in altered expression of ~800 genes upon p53 activation, revealing a context-dependent function of <i>PURPL</i>. Pathway analysis suggested that <i>PURPL</i> is important for fine-tuning the expression of specific genes required for mitosis. Consistent with these results, we observed a significant decrease in the percentage of mitotic cells upon <i>PURPL</i> depletion. Collectively, these data identify novel transcripts from the <i>PURPL</i> locus and suggest that <i>PURPL</i> delicately moderates the expression of mitotic genes in the context of p53 activation to control cell cycle arrest.</p>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753727/pdf/mcb.00289-22.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1128/mcb.00289-22","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 2
Abstract
PURPL is a p53-induced lncRNA that suppresses basal p53 levels. Here, we investigated PURPL upon p53 activation in liver cancer cells, where it is expressed at significantly higher levels than other cell types. Using isoform sequencing, we discovered novel PURPL transcripts that have a retained intron and/or previously unannotated exons. To determine PURPL function upon p53 activation, we performed transcriptome sequencing (RNA-Seq) after depleting PURPL using CRISPR interference (CRISPRi), followed by Nutlin treatment to induce p53. Strikingly, although loss of PURPL in untreated cells altered the expression of only 7 genes, loss of PURPL resulted in altered expression of ~800 genes upon p53 activation, revealing a context-dependent function of PURPL. Pathway analysis suggested that PURPL is important for fine-tuning the expression of specific genes required for mitosis. Consistent with these results, we observed a significant decrease in the percentage of mitotic cells upon PURPL depletion. Collectively, these data identify novel transcripts from the PURPL locus and suggest that PURPL delicately moderates the expression of mitotic genes in the context of p53 activation to control cell cycle arrest.